beta-adrenergic antagonist
An agent that binds to but does not activate beta-adrenergic receptors thereby blocking the actions of endogenous or exogenous beta-adrenergic agonists. beta-Adrenergic antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches and anxiety.
|
|
beta-adrenergic antagonist
An agent that binds to but does not activate beta-adrenergic receptors thereby blocking the actions of endogenous or exogenous beta-adrenergic agonists. beta-Adrenergic antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches and anxiety.
antihypertensive agent
Any drug used in the treatment of acute or chronic vascular hypertension regardless of pharmacological mechanism.
vasodilator agent
A drug used to cause dilation of the blood vessels.
bronchoconstrictor agent
A drug which causes a narrowing of the lumen of a bronchus or bronchiole.
hematologic agent
Drug that acts on blood and blood-forming organs and those that affect the hemostatic system.
|
|
(2R)-2-acetoxy-3-(octadecyloxy)propyl 2-(trimethylammonio)ethyl phosphate
|
(2RR)-2-acetoxy-3-(octadecyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate
|
(−)-1-O-octadeyl-2-O-acetyl-sn-glycerylphosphocholine
|
ChEBI
|
(R)-7-(acetyloxy)-4-hydroxy-N,N,N-trimethyl-3,5,9-trioxa-4-phosphaheptaconasan-1-aminium hydroxide inner salt 4-oxide
|
ChEBI
|
1-0-octadecyl 2-0-acetyl sn-glycero-3-phosphorylcholine
|
ChemIDplus
|
1-O-octadecyl 2-O-acetyl sn-glycero-3-phosphorylcholine
|
ChemIDplus
|
1-O-octadecyl-2-acetyl-sn-glycero-3-phosphocholine
|
UniProt
|
1-O-octadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine
|
ChemIDplus
|
1-O-octadecyl-2-O-acetyl-sn-glycero-3-phosphocholine
|
ChEBI
|
1-O-octadecyl-2-O-acetyl-sn-glyceryl-3-phosphorylcholine
|
ChemIDplus
|
1-O-octadecyl-PAF
|
ChEBI
|
1-O-Octadecyl-platelet-activating factor
|
ChemIDplus
|
1-O-octadecyl-platelet-activating factor
|
ChemIDplus
|
1-O-Stearoyl-2-acetyl-sn-glyceryl-3-phosphorylcholine
|
ChemIDplus
|
1-O-Stearyl-2-acetyl-sn-glyceryl-3-phosphorylcholine
|
ChemIDplus
|
1-octadecyl-2-acetyl-sn-glycero-3-phosphocholine
|
LIPID MAPS
|
acetyl-glyceryl-ether-phosphorylcholine
|
SUBMITTER
|
AGEPC
|
SUBMITTER
|
blood platelet activating factor-acether
|
LIPID MAPS
|
Blood platelet activating factor-aether
|
ChemIDplus
|
Blood platelet-activating factor
|
ChemIDplus
|
Blood platelet-activating factor
|
ChemIDplus
|
C18-Paf
|
ChemIDplus
|
C18-PAF
|
ChEBI
|
C18-PAF-acether
|
LIPID MAPS
|
C18:0 PAF
|
ChEBI
|
PAF
|
SUBMITTER
|
PAF acether
|
LIPID MAPS
|
PAF-acether
|
SUBMITTER
|
PC(O-18:0/2:0)
|
SUBMITTER
|
PC(O-18:0/2:0)
|
LIPID MAPS
|
phosphatidylcholine (O-18:0/2:0)
|
SUBMITTER
|
platelet activating factor
|
ChEBI
|
platelet activating factor-acether
|
LIPID MAPS
|
Platelet-activating factor
|
ChemIDplus
|
platelet-activating factor
|
LIPID MAPS
|
Ro 14-8161
|
LIPID MAPS
|
5364572
|
Reaxys Registry Number
|
Reaxys
|
5364572
|
Beilstein Registry Number
|
Beilstein
|
5364572
|
Reaxys Registry Number
|
Reaxys
|
74389-69-8
|
CAS Registry Number
|
ChemIDplus
|
74389-69-8
|
CAS Registry Number
|
ChemIDplus
|